Concepedia

Frank Boess

FB

Statistics

Publications

42

Citations

4K

H-Index

28

Active since

1990

Affiliations

Roche (Switzerland)(Current)

Prothena (United States)

University of California San Diego

Eli Lilly (Germany)

Bayer (Germany)

Frank Boess is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1990–2025

42

Publications

42

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

Viktor Lakics, Eric Karran, Frank Boess · Neuropharmacology · 2010 · 464 citations

Life Sciences, Molecular Biology, Neuroscience +8

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

Gennaro Pagano, Kirsten I. Taylor, Judith Anzures‐Cabrera et al. · New England Journal of Medicine · 2022 · 395 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

Frank Boess, Martin Hendrix, F. Josef van der Staay et al. · Neuropharmacology · 2004 · 325 citations

Life Sciences, Neurobiology, Neuroscience +15

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease

Joseph Jankovic, Ira Goodman, Beth Safirstein et al. · JAMA Neurology · 2018 · 292 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Florian Lipsmeier, Kirsten I. Taylor, Timothy Kilchenmann et al. · Movement Disorders · 2018 · 268 citations · Full text

Health Professions, Health Informatics, Neurology +17

1–5 of 42